It was also suggested that EpCAM expression may be associated with CRC carcinogenesis, while the loss of EpCAM expression can be correlated with the progression, metastasis, and poor prognosis of CRC, which makes EpCAM a useful biomarker for the clinical diagnosis of CRC [14]. This evidence concerns the gene EPCAM and colorectal carcinoma.